1. Home
  2. ACTU vs GDO Comparison

ACTU vs GDO Comparison

Compare ACTU & GDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACTU
  • GDO
  • Stock Information
  • Founded
  • ACTU 2015
  • GDO 2009
  • Country
  • ACTU United States
  • GDO United States
  • Employees
  • ACTU N/A
  • GDO N/A
  • Industry
  • ACTU
  • GDO Finance Companies
  • Sector
  • ACTU
  • GDO Finance
  • Exchange
  • ACTU NYSE
  • GDO Nasdaq
  • Market Cap
  • ACTU 153.1M
  • GDO 182.8M
  • IPO Year
  • ACTU 2024
  • GDO N/A
  • Fundamental
  • Price
  • ACTU $8.06
  • GDO $12.98
  • Analyst Decision
  • ACTU
  • GDO
  • Analyst Count
  • ACTU 0
  • GDO 0
  • Target Price
  • ACTU N/A
  • GDO N/A
  • AVG Volume (30 Days)
  • ACTU 38.3K
  • GDO 39.4K
  • Earning Date
  • ACTU 01-01-0001
  • GDO 01-01-0001
  • Dividend Yield
  • ACTU N/A
  • GDO 9.81%
  • EPS Growth
  • ACTU N/A
  • GDO N/A
  • EPS
  • ACTU N/A
  • GDO N/A
  • Revenue
  • ACTU N/A
  • GDO N/A
  • Revenue This Year
  • ACTU N/A
  • GDO N/A
  • Revenue Next Year
  • ACTU N/A
  • GDO N/A
  • P/E Ratio
  • ACTU N/A
  • GDO N/A
  • Revenue Growth
  • ACTU N/A
  • GDO N/A
  • 52 Week Low
  • ACTU $7.33
  • GDO $11.21
  • 52 Week High
  • ACTU $10.16
  • GDO $13.04
  • Technical
  • Relative Strength Index (RSI)
  • ACTU N/A
  • GDO 72.30
  • Support Level
  • ACTU N/A
  • GDO $12.78
  • Resistance Level
  • ACTU N/A
  • GDO $13.01
  • Average True Range (ATR)
  • ACTU 0.00
  • GDO 0.06
  • MACD
  • ACTU 0.00
  • GDO 0.01
  • Stochastic Oscillator
  • ACTU 0.00
  • GDO 83.87

About ACTU ACTUATE THERAPEUTICS INC

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3β, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.

About GDO Western Asset Global Corporate Defined Opportunity Fund Inc.

Western Asset Global Corp Defined Opp is a closed-end management investment company with a primary investment objective to provide current income. Its secondary objective is to seek capital appreciation. The Fund invests in the United States and foreign corporate fixed-income securities of varying maturities.

Share on Social Networks: